These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. CRISPR-Cas9 editing of non-coding genomic loci as a means of controlling gene expression in the sea urchin. Pieplow A; Dastaw M; Sakuma T; Sakamoto N; Yamamoto T; Yajima M; Oulhen N; Wessel GM Dev Biol; 2021 Apr; 472():85-97. PubMed ID: 33482173 [TBL] [Abstract][Full Text] [Related]
47. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a. Shin HR; Kweon J; Kim Y Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383 [TBL] [Abstract][Full Text] [Related]
48. Generation of gene-of-interest double allele knockout clones in primary human T cells by CRISPR. Wu L; Tan JC; Gascoigne NRJ STAR Protoc; 2023 Sep; 4(3):102445. PubMed ID: 37432856 [TBL] [Abstract][Full Text] [Related]
50. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes. Kumar R; Tiwari K; Saudagar P Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478 [TBL] [Abstract][Full Text] [Related]
51. Genome Editing with CRISPR-Cas9: Can It Get Any Better? Haeussler M; Concordet JP J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042 [TBL] [Abstract][Full Text] [Related]
52. Genome Editing in Mice Using CRISPR/Cas9 Technology. Hall B; Cho A; Limaye A; Cho K; Khillan J; Kulkarni AB Curr Protoc Cell Biol; 2018 Dec; 81(1):e57. PubMed ID: 30178917 [TBL] [Abstract][Full Text] [Related]
53. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems. Briner AE; Barrangou R Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605 [TBL] [Abstract][Full Text] [Related]
54. A Robust Protocol for CRISPR-Cas9 Gene Editing in Human Suspension Cell Lines. Wardyn JD; Chan ASY; Jeyasekharan AD Curr Protoc; 2021 Nov; 1(11):e286. PubMed ID: 34748280 [TBL] [Abstract][Full Text] [Related]
55. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii. Shen B; Brown K; Long S; Sibley LD Methods Mol Biol; 2017; 1498():79-103. PubMed ID: 27709570 [TBL] [Abstract][Full Text] [Related]
56. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in Wang Y; Wang Z; Ji Q STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078 [TBL] [Abstract][Full Text] [Related]
57. Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors. Lane-Reticker SK; Kessler EA; Muscato AJ; Kim SY; Doench JG; Yates KB; Manguso RT; Dubrot J STAR Protoc; 2023 Mar; 4(1):102082. PubMed ID: 36861834 [TBL] [Abstract][Full Text] [Related]
58. A Multiplexed CRISPR/Cas9 Editing System Based on the Endogenous tRNA Processing. Xie K; Yang Y Methods Mol Biol; 2019; 1917():63-73. PubMed ID: 30610628 [TBL] [Abstract][Full Text] [Related]
59. Generation of Mouse Model (KI and CKO) via Easi-CRISPR. Shola DTN; Yang C; Han C; Norinsky R; Peraza RD Methods Mol Biol; 2021; 2224():1-27. PubMed ID: 33606203 [TBL] [Abstract][Full Text] [Related]
60. Nanoscale metal-organic frameworks for the intracellular delivery of CRISPR/Cas9 genome editing machinery. Zheng Q; Li W; Mao L; Wang M Biomater Sci; 2021 Oct; 9(21):7024-7033. PubMed ID: 34378567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]